From the Journal

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?

Robert M. Cooper, MBChB, MRCP1,2;  Adeel Shahzad, MBBS, MRCP1,2;  James McShane2;  Rodney H. Stables, MA (Cantab), DM (Oxon), BM BCH (Oxon)1,2

A retrospective case series reviewing all patients undergoing alcohol septal ablation at a United Kingdom tertiary referral center from 2000-2012 with the aim of describing aggregate and individual outcomes in terms of symptomatic and hemodynamic response.  ...

Impact of a Disposable Sterile Radiation Shield on Operator Radiation Exposure During Percutaneous Coronary Intervention of Chronic Total Occlusions

Deborah Shorrock1,2;  Georgios Christopoulos, MD1;  Jedrek Wosik, MD1;  Anna Kotsia, MD1;  Bavana Rangan, BDS, MPH1;  Shuaib Abdullah, MD1;  Daisha Cipher, MD1;  Subhash Banerjee, MD1;  Emmanouil S. Brilakis, MD, PhD1  

Daily radiation exposure in the cath lab over many years can adversely impact the health of medical professionals. This study recorded operator radiation exposure at a single institution and compared exposure of operators using the Radpad disposable radiation protection sterile drape in all CTO-PCI cases, versus no protection for operators in non-CTO PCI cases. ...

Physician, Shield Thyself!

Srikanth Vallurupalli, MD and Barry F. Uretsky, MD

CTO-PCI operators should plan effective shielding techniques to minimize risk to themselves and their lab personnel and consider use of the Radpad drape when a case is expected to require a relatively high radiation dose....

Ahead of Print

Efficacy and Safety of Transcatheter Aortic Valve Implantation in Aortic Stenosis Patients With Extreme Age

Katia Orvin, MD;  Abid Assali, MD;  Hana Vaknin-Assa, MD;  Amos Levi, MD;  Gabi Greenberg, MD; 

Pablo Codner, MD;  Yaron Shapira, MD;  Alex Sagie, MD;  Ran Kornowski, MD

Published online ahead of print on 2015 Jul 15

The in-hospital and long-term outcomes of patients at extreme age with severe symptomatic aortic stenosis who underwent transcatheter aortic valve implantation are investigated. Meticulously selected patients at extreme age benefit from TAVI with a reasonable overall risk, which does not impact the overall survival or functional status. 

Effect of Prior Aspirin Treatment on Patients With Acute Coronary Syndromes: Insights From the PROSPECT Study

Sorin J. Brener, MD,1,2;  Akiko Maehara, MD,2,3;  Gary S. Mintz, MD2;  Giora Weisz, MD,2,3,4

Bernard de Bruyne, MD, PhD5;  Patrick W. Serruys, MD, PhD6;  Gregg W. Stone, MD2,3

Published online ahead of print on 2015 Jul 15

Prior aspirin treatment is considered a risk factor for adverse outcomes in ACS patients. This PROSPECT trial analysis of patients with versus without aspirin pretreatment indicates that aspirin pretreatment was not an independent predictor of MACE in ACS patients treated with an early invasive strategy.

Lack of Survival Benefit Found With Use of Intraaortic Balloon Pump in Extracorporeal Membrane Oxygenation: A Pooled Experience of 1517 Patients

Richard Cheng, MD1;  Rory Hachamovitch, MD2;  Raj Makkar, MD1;  Danny Ramzy, MD, PhD3;  

Jaime D. Moriguchi, MD1;  Francisco A. Arabia, MD3;  Fardad Esmailian, MD3;  Babak Azarbal, MD1,4

Published online ahead of print on 2015 Jul 15

Intraaortic balloon pumps (IABPs) are frequently used as an adjunctive device to extracorporeal membrane oxygenation (ECMO) and are routinely placed at the initiation of ECMO at many institutions. We provide a meta-analysis to demonstrate that the routine insertion of concomitant IABP with ECMO is not supported by our findings.


Back to top